ArticleCancer immunology, immunotherapy : CII2025

Biomarker, efficacy and safety analysis of transcatheter arterial chemoembolization combined with atezolizumab and bevacizumab for unresectable hepatocellular carcinoma.

Shaobo Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.